版本:
中国

BRIEF-Quidel receives FDA clearance for Solana(R) molecular assay for detecting C. difficile infections

May 11 Quidel Corp:

* Quidel receives FDA clearance for its new Solana(R) molecular assay for the detection of Clostridium difficile (C. difficile) infections

* Received 510(k) clearance from U.S. FDA to market its Solana C. difficile Assay for detection of Clostridium difficile (C. difficile) infections Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐